Equasens

Q3 2023 revenue

Villers-lès-Nancy, 9 November 2023 - 6:00 p.m. (CET)

PRESS RELEASE

Q3 2023 revenue

• Q3 2023 revenue: stable year-on-year at €50.1m
• Growth impacted by:
  • The completed deployment of solutions under the Ségur French Digital Healthcare investment programme:
  • Adverse market conditions affecting Pharmacy sector.

In €m	2022	2023	Change 2023 / 2022
Q1	49.4	56.3	+14% (*)
Q2	54.2	56.3	4 %
Q3 (unaudited)	50.1	50.1	0 %
9 month YTD	153.7	162.7	6 %

^(*) Strong growth in Q1 reflecting a favourable comparison base (restructuring of the electronic labelling activity).

____________

Q3 2023 business highlights:

• The PHARMAGEST Division reported revenue of €36.8m, marginally down on Q3 2022 (-1%). For the first 9 months, revenue rose 6% to €120.5m.
  • The hardware configuration business was down in relation to Q3 2022, reflecting notably completion of the technical compliance campaign for the installed base combined with the rollout of Ségur functionalities.
  • The economic environment impacted by inflation and rising operating costs, combined with a financial context unfavourable for investment, also adversely impacted equipment purchases by pharmacies, including for electronic labels.
  • Driven by the success of new offerings, and in particular messaging, mobility and back-up solutions, sales of licenses and services remain buoyant.
  • Recurring revenue continue to show strong growth.
  • This Division accounted for 74 % of Equasens Group's total revenue.

• The AXIGATE LINK Division had revenues of €7.4m, up 6% on Q3 2022. Revenue for the first 9 months rose 6% to €22.3m.
  • The Division is continuing to grow in its historical market segments of nursing homes and hospital-at-home care.
  • The TITANLINK solution continues to display strong growth, particularly in Belgium, as new functionalities, such as CARELIB, are being integrated into the software.
  • This Division accounted for 14 % of Equasens Group's total revenue.

• The E-CONNECT Division had revenue of €3.6m, with strong growth of 23% compared with Q3 2022. Revenue for the first nine months rose 13% to €11.7m.
  • Once again, the Division registered a very good performance for the quarter: Mobility solutions have been a genuine success, made possible by the Division's ability to meet the challenges of production capacity and component sourcing.
  • This Division accounted for 7 % of Equasens Group's total revenue.